Growing community of inventors

Lund, Sweden

Anders Grubb

Average Co-Inventor Count = 3.87

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Anders GrubbFranciszek Kasprzykowski (4 patents)Anders GrubbRegina Kasprzykowska (4 patents)Anders GrubbUlf Lerner (2 patents)Anders GrubbAftab Jasir (2 patents)Anders GrubbBeata Zolnowska (2 patents)Anders GrubbClaes Schalén (2 patents)Anders GrubbHenrik Dalboge (1 patent)Anders GrubbAke Lundwall (1 patent)Anders GrubbNaghi Momeni (1 patent)Anders GrubbMagnus Abrahamson (1 patent)Anders GrubbAnders Grubb (6 patents)Franciszek KasprzykowskiFranciszek Kasprzykowski (4 patents)Regina KasprzykowskaRegina Kasprzykowska (4 patents)Ulf LernerUlf Lerner (2 patents)Aftab JasirAftab Jasir (2 patents)Beata ZolnowskaBeata Zolnowska (2 patents)Claes SchalénClaes Schalén (2 patents)Henrik DalbogeHenrik Dalboge (3 patents)Ake LundwallAke Lundwall (2 patents)Naghi MomeniNaghi Momeni (1 patent)Magnus AbrahamsonMagnus Abrahamson (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Strongbone Ab (2 from 2 patents)

2. Neobiotics Ab (2 from 2 patents)

3. Novo Nordisk A/s (1 from 1,781 patents)

4. Autism Biodiagnostic Ltd (1 from 1 patent)


6 patents:

1. 9169289 - Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

2. 8748370 - Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

3. 8268576 - Diagnosis of autism

4. 8097582 - Peptide derivatives useful as antimicrobial agents and for treating wounds

5. 7691805 - Antimicrobial compounds

6. 5432264 - Recombinant 3-des-OH-cystatin C produced by expression in a procaryotic

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/18/2026
Loading…